BioOptics Stock Watch
Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Eli Lilly (NY: LLY)
122.13 USD  -0.35 (-0.29%)
Official Closing Price  /  Updated: 5:44 PM EST, Feb 19, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 17,861,295
Open 121.31
Bid (Size) 122.01 (1)
Ask (Size) 122.17 (2)
Prev. Close 122.48
Today's Range 121.30 - 123.33
52wk Range 74.51 - 123.33
Shares Outstanding 1,085,430,420
Dividend Yield 1.84%
Performance
YTD
+6.31%
+6.31%
1 Month
+4.30%
+4.30%
3 Month
+5.46%
+5.46%
6 Month
+15.41%
+15.41%
1 Year
+57.49%
+57.49%
Top News
More News
Pfizer and Lilly Announce Top-line Results From Phase 3 Study of Tanezumab in Chronic Low Back Pain
Pfizer Inc. (NYSE: PFE) and Eli Lilly and Company (NYSE: LLY) today announced positive top-line results from a Phase 3 study evaluating tanezumab in patients with moderate-to-severe chronic low back... Read More
from PR Newswire
Lilly Completes Acquisition of Loxo Oncology
Eli Lilly and Company (NYSE:LLY) today announced the successful completion of its acquisition of Loxo Oncology, Inc. (NASDAQ:LOXO). The acquisition broadens the scope of Lilly's oncology portfolio into... Read More
from PR Newswire
More News
Read More
Lilly To Participate in Leerink Partners Global Healthcare Conference
from PR Newswire
Boehringer Ingelheim and Lilly announce the CAROLINA® cardiovascular outcome trial of Tradjenta® met its primary endpoint of non-inferiority compared with glimepiride
from PR Newswire
Hagens Berman: Judge Denies Insulin Makers’ Motion to Dismiss Class-Action Lawsuit Regarding Skyrocketing Insulin Prices
from Business Wire News Releases
UPDATE 1-Pfizer-Lilly drug shown to help reduce back pain in late-stage trial
category companyNews
from Reuters: Company News
Higher dose of Pfizer-Lilly drug helps reduce back pain in study
category companyNews
from Reuters: Company News
Hot Options Report For End Of Day - Tuesday, Feb. 19
category Options
from Blogs - TalkMarkets
Most Active Equity Options And Strikes For Midday - Tuesday, Feb. 19
category Options
from Blogs - TalkMarkets
UPDATE 1-Bayer gains full Vitrakvi rights from Eli Lilly's Loxo
category companyNews
from Reuters: Company News
Bayer acquires full Vitrakvi rights from Eli Lilly's Loxo
category companyNews
from Reuters: Company News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.